AbbVie (NY: ABBV )
152.98 -0.45 (-0.29%) Streaming Delayed Price Updated: 10:35 AM EDT, Sep 22, 2023 Add to My Watchlist
Press Releases about AbbVie
High Yield, Low Beta Stocks to Buy for the Next Market Meltdown
September 12, 2023
The market is set up for a fall, and it may start soon, as soon as the CPI data is released. These low-beta stocks are poised to outperform and pay dividends
Investors have had to digest some negative news headlines, but if you look past that a dividend king like JNJ can be a boring but reliable buy in this market
Exposures Intellectual Property
Johnson & Johnson: Taking The Bull By The Horns?
February 21, 2023
Johnson & Johnson is rushing toward a patent cliff but a new shelf offering registration suggests itis gearing up for acquisitions.
AbbVie Has a Mixed Outlook After Mixed Earnings
February 13, 2023
AbbVie stock was up after posting a mixed fourth-quarter earnings report, but with the company's patent expiring on Humira, the stock is a hold